Your browser is no longer supported. Please, upgrade your browser.
Settings
IBB iShares Nasdaq Biotechnology ETF daily Stock Chart
IBB [NASD]
iShares Nasdaq Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-5.28%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.90%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter12.43%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.41 Perf Half Y-8.07%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-2.26%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range89.01 - 122.97 Perf YTD12.17%
Dividend0.18 P/FCF- EPS past 5Y- ROI- 52W High-12.04% Beta-
Dividend %0.17% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low21.53% ATR2.06
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)39.78 Volatility1.88% 1.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.50 Prev Close111.97
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.33M Price108.17
Recom- SMA20-3.82% SMA50-2.08% SMA200-2.72% Volume3,560,119 Change-3.39%
Mar-25-19 05:04AM  5 biotech stocks that could be the next big winners MarketWatch
Mar-21-19 11:16AM  Biotech Funds Could Generate Profitable Short Sales Investopedia
09:46AM  Biogen shares tank nearly 30% after pulling key Alzheimers drug trial Yahoo Finance
06:52AM  Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the role MarketWatch
Mar-20-19 07:07AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Mar-18-19 03:05PM  Aerpio Pharmaceuticals stock plummets after failed trial of diabetic retinopathy treatment MarketWatch
01:12PM  Dare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment study MarketWatch
07:29AM  PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent MarketWatch
Mar-14-19 03:51PM  Gilead Stock Could Surge to $84, Says Analyst Barrons.com
Mar-13-19 10:35AM  Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting MarketWatch
Mar-11-19 12:27PM  Is iShares Nasdaq Biotechnology Index Fund a Buy? Motley Fool
Mar-10-19 02:32PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs Benzinga
Mar-05-19 03:32PM  Biotech stocks turn lower after reports of FDA commissioner resigning MarketWatch
08:00AM  CNBC ETF Edge: Biotech Getting Sick? ETF.com
Mar-04-19 01:44PM  How you should trade the biotech ETFs CNBC Videos
08:39AM  Nightstar Therapeutics' stock rockets on Biogen buyout deal valued at $877 million MarketWatch
Mar-01-19 06:51AM  Immunogen's stock loses nearly half its value after trial of cancer treatment fails to meet primary endpoint MarketWatch
Feb-27-19 03:00PM  7 of the Best Biotech ETFs InvestorPlace
Feb-25-19 05:54PM  Technician says it's time to fade the biotech rally CNBC Videos
Feb-20-19 09:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Feb-14-19 01:00PM  Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings Zacks
Feb-12-19 03:21PM  Anchiano Therapeutics' stock set to close well below its IPO price MarketWatch
09:29AM  Anchiano Therapeutics IPO prices below assumed price MarketWatch
Feb-07-19 10:49AM  Alector's stock opens below IPO price, then swings above it MarketWatch
Jan-29-19 08:56AM  Biogen Stock Running in Place Despite Strong Quarter Investopedia
Jan-28-19 08:52AM  Amgen downgraded to in-line from outperform by Evercore ISI MarketWatch
Jan-25-19 01:36PM  MacroGenics stock gains 4% after FDA lifts partial clinical hold MarketWatch
10:02AM  Intuitive Surgical Stock Dips Are Buying Opportunities InvestorPlace
08:32AM  NuCana's stock soars after withdrawing ADS offering, which triggered a big selloff MarketWatch
Jan-24-19 01:00PM  What's Behind the Biotech ETF Rally to Start 2019? Zacks
Jan-23-19 07:51AM  Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols MarketWatch
Jan-22-19 11:06AM  Editas stock down 21% after announcing CEO departure MarketWatch
09:17AM  Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data MarketWatch
Jan-17-19 09:10AM  Lipocine's stock rockets on premarket leading volume after upbeat liver fat study results MarketWatch
07:13AM  Trade of the Day: The Biotechnology Stocks ETF Is Running Out of Steam InvestorPlace
Jan-16-19 09:19AM  Aptinyx stock falls 67% after phase 2 trial fails to meet primary endpoint MarketWatch
Jan-14-19 06:00PM  Democrats target drug prices CNBC Videos
Jan-11-19 10:59AM  Why Sarepta Therapeutics Stock Is Starting to Shine Again InvestorPlace
08:30AM  Bear market in value stocks is ending, Wells Fargo predicts a 2019 comeback CNBC
Jan-08-19 08:00AM  Two ways to play the biotech boom CNBC
07:24AM  Biotech's breaking out, and here's why some market experts think an even bigger rally is ahead CNBC
Jan-07-19 01:27PM  Sage Therapeutics's stock shoots higher after postpartum depression treatment's positive trial results MarketWatch
12:53PM  ETF Edge, January 7, 2019 CNBC Videos
12:26PM  ETF Edge: Biotech breakout CNBC Videos
08:23AM  Axsome's stock nearly triples on heavy volume after positive trial of depression treatment MarketWatch
Jan-04-19 04:35PM  Insmed stock shoots up 18% after company says it expects drug Arikayce to bring in $9.8 million in fourth quarter MarketWatch +5.03%
10:01AM  Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus Zacks
07:13AM  Mersana to discontinue development of one cancer treatment to focus on another MarketWatch
Dec-31-18 09:00AM  Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates Benzinga
08:52AM  Heron stock up 4.3% after opioid alternative granted priority review designation from FDA MarketWatch
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-26-18 02:22PM  6 Valuable Pipeline Drugs With Upcoming Catalysts Benzinga +5.80%
Dec-20-18 04:42PM  Mirati Therapeutics Added To NASDAQ Biotechnology Index PR Newswire
Dec-18-18 12:25PM  Is iShares NASDAQ Biotechnology Index (ETF) (IBB) A Good Stock To Buy? Insider Monkey
09:43AM  Best ETFs of 2019: Financial Select Sector SPDR Fund Will Rise Again InvestorPlace
Dec-17-18 07:00AM  Market Morning: Rate Hike Ahead, Obamacare Struck Down, JNJ Asbestos Scandal, Qatar Challenges Saudis Market Exclusive
Dec-13-18 07:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Dec-12-18 03:17AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen Zacks
Dec-11-18 03:32PM  Trump Foreshadows a Bleak Outlook for Biotech (IBB, BIB) Investopedia
Dec-10-18 09:24AM  IBBs $100 Support Level Goes Back to 2017 InvestorPlace
Dec-07-18 11:48AM  Shares of Moderna open at $22, 4% lower than IPO price MarketWatch
Dec-04-18 02:08PM  Revance Therapeutics reaches licensing agreement with Fosun Pharmaceutical over botox formulation RT002 MarketWatch
Nov-26-18 07:07AM  Zafgen's IND for diabetes treatment placed on hold by FDA MarketWatch
Nov-21-18 02:17PM  Pfizer Stock Has Multiple Positive Catalysts InvestorPlace
09:47AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Nov-20-18 02:03PM  7 Biotech ETFs to Consider for 2019 InvestorPlace
Nov-14-18 03:09PM  Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels MarketWatch
Nov-11-18 09:10AM  The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Nov-07-18 09:55AM  MiMedx stock plunges after receiving delisting notice from Nasdaq MarketWatch
Nov-02-18 05:18PM  Stocks finish lower after a volatile trading session Yahoo Finance Video
05:12PM  Newman: GOP still trying to kill the Affordable Care Act Yahoo Finance Video
08:52AM  Puma Biotechnology's stock plunges to pace premarket losers after key drug Nerlynx disappoints MarketWatch
Nov-01-18 04:09PM  Small Cap Stocks, Chips Lead Broad Gains, But This Group Surprisingly Lags Investor's Business Daily
Oct-25-18 05:41PM  Technician reacts to Gilead earnings and the biotech spac... CNBC Videos
08:00AM  Chip Stocks Plunge In Severe Market Rout, But These Sectors Rise Investor's Business Daily
Oct-19-18 12:15PM  Biotech Sector Could Enter Bear Market Investopedia
07:46AM  Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated MarketWatch
Oct-12-18 11:15AM  Equillium's stock opens 2.5% above IPO price MarketWatch
08:57AM  Immune Design's stock plummets toward record low after cancer vaccine program discontinued MarketWatch
08:16AM  Corium's stock rockets to pace premarket gainers after Gurnet buyout deal MarketWatch
Oct-10-18 12:56PM  Biotech ETF IBB is down 6% in one way, here's why CNBC Videos
Oct-04-18 11:35AM  Kodiak Sciences' stock trades little changed in its debut, after the IPO prices well below the expected range MarketWatch
10:55AM  Guardant Health's stock soars in public debut after IPO prices above expectations MarketWatch
08:47AM  Vaxart's stock soars after upbeat results from oral flu vaccine trial MarketWatch
Oct-03-18 05:30PM  Chartmaster says it's time to fade one of this year's bes... CNBC Videos
Sep-27-18 08:04AM  Geron's stock plunges to pace all premarket losers after Janssen terminates CLA MarketWatch
Sep-26-18 08:12AM  Alderya's stock rockets after positive trial results of mesothelioma treatment MarketWatch
06:51AM  Alexion Pharmaceuticals to buy Syntimmune for up to $1.2 billion, including potential milestone payments MarketWatch
Sep-24-18 09:20AM  Three options strategies for the week: Sept 24 CNBC
07:45AM  Epizyme's stock soars after FDA lifts hold on trial enrollments MarketWatch
Sep-21-18 02:30PM  Is iShares Nasdaq Biotechnology ETF a Buy? Motley Fool
09:09AM  Novavax's stock soars after J.P. Morgan swings to bullish from bearish ahead of trial results MarketWatch
Sep-19-18 09:41AM  G1 Therapeutics' stock drops on heavy volume after stock offering MarketWatch
08:15AM  Molecular Templates' stock soars after development deal with Takeda MarketWatch
Sep-17-18 07:56AM  Gritstone Oncology sets terms for IPO to raise up to $91.1 million MarketWatch
07:24AM  Realm Therapeutics launches review that may include a sale after disappointing trial results MarketWatch
Sep-12-18 06:00PM  Bluebird Bio Stock May Have Upside of at Least 60 Percent InvestorPlace
Sep-11-18 10:57AM  Vivus stock rallies above $5 mark in volatile trade after reverse stock split takes effect MarketWatch
Sep-10-18 01:23PM  Three options strategies for the week: Sept 10 CNBC
Sep-07-18 02:10PM  Arrowhead Stock Is Not Done Rallying After Its 38% Jump InvestorPlace
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.